期刊
JOURNAL OF CLINICAL MEDICINE
卷 10, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/jcm10091947
关键词
COVID-19; SARS-CoV-2; neurology; brain damage; post-scute COVID-19 neurological syndrome
The emergence of the highly pathogenic coronavirus SARS-CoV-2 in China in December 2019 led to the global spread of COVID-19, causing devastating socio-economic impacts and necessitating a focus on vulnerable groups. Scientific evidence suggests the importance of monitoring symptoms following acute infection, with a significant number of patients experiencing neurological complications even after recovery.
In December 2019, in Wuhan (China), a highly pathogenic coronavirus, named SARS-CoV-2, dramatically emerged. This new virus, which causes severe pneumonia, is rapidly spreading around the world, hence it provoked the COVID-19 pandemic. This emergency launched by SARS-CoV-2 also had, and still has, devastating socio-economic aspects. Assessing the impact of COVID-19 on vulnerable groups of people is crucial for the adaptation of governments' responses. Growing scientific evidence suggests that it is essential to keep the attention on people after acute SARS-CoV-2 infection; indeed, some clinical manifestations are frequently present even after recovery. There is consensus on the need to define which symptoms persist after the infection and which disabilities may arise after COVID-19. Recent reviews, case reports, and original contributions suggest that various organs may be affected, and neurological symptoms are present in about one third of patients with COVID-19. Neurological complications after severe COVID-19 infection might include delirium, brain inflammation, stroke, and nerve damage. In the recent pandemic, neurologists and neurobiologists have a chance to study key features of infection neurology. Furthermore, the psychological impact of the pandemic should not be underestimated, although there is currently no definition for this condition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据